Corporate Profile

lab_2

Using biotechnology as a forensic foundation, Applied DNA Sciences creates unique security solutions addressing the challenges of modern commerce. Whether for supply chain security, brand protection or law enforcement applications, it is our goal to help establish secure flourishing environments that foster quality, integrity and success.


With secure taggants, high-resolution DNA authentication, and comprehensive reporting, our plant-based DNA technologies are designed to deliver what we believe to be the greatest levels of security, deterrence and legal recourse strength. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction (“PCR”).

Management Team

James A. Hayward, Phd., Sc.D

HaywardJames-1-300x239

Chairman of the Board, President and Chief Executive Officer

Beth Jantzen

JantzenBeth

Chief Financial Officer

Judy Murrah

Judy Murrah, Chief Information Officer

Chief Information Officer

Stock Information

APDN
2.58
+0.08
+3.20%
 
NASDAQ
6370.59
-56.329
-0.8765%
 
S&P500
2496.66
-5.56
-0.22%
 
NYSE
12141.6
-10.231
-0.084%
 
APDN
2.58
+0.08
+3.20%
 
NASDAQ
6370.59
-56.329
-0.8765%
 
S&P500
2496.66
-5.56
-0.22%
 
NYSE
12141.6
-10.231
-0.084%
 

 S&PButton

Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, NY 11790
tel: 212.838.3777
fax: 631.240.8900
Email: investor@adnas.com

American Stock Transfer and Trust Company
6201 15th Ave.
Brooklyn, New York 11219
Tel: 718.921.8210
Fax: 718.921.8355
http://www.amstock.com/main/

For additional information, please click here.

Brian Kintslinger, CFA
Maxim Group
http://www.maximgrp.com/

Important Note

Applied DNA Sciences. Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Applied DNA’s performance made by the analyst(s) are theirs alone and do not represent opinions, forecasts or predictions of Applied DNA or its management. Applied DNA does not by its reference above imply its endorsement of or concurrence with such information, conclusions or recommendations. This list includes analyst(s) currently known by Applied DNA to follow the company, but may not be complete and may change as firms add or delete coverage. Applied DNA does not undertake any duty to update this information or any information provided by third parties.
Merrill Kraines
Pepper Hamilton LLP
New York Times Building
620 Eighth Avenue/37th Floor
New York, New York 10018-1405
Phone: 212-808-2711
krainesm@pepperlaw.com
.
Applied DNA Sciences is not able to purchase shares on your behalf, and it is not possible for you to purchase shares directly from us. Please contact a stockbroker, bank, or independent financial advisor, who should be able to act on your behalf.

To view our SEC filings, please click here

Marcum LLP
10 Melville Park Road
Melville, NY 11790
tel: 631 414 4000
fax: 631 414 4001
http://www.marcumllp.com

The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, and our subsequent quarterly reports on Form 10-Q, which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Newsroom

APDN to Present at 2017 Disruptive Growth Company Showcase

APDN to Present at 2017 Disruptive Growth Company Showcase

APDN Files Form S-3 Registration Statement

APDN Files Form S-3 Registration Statement

APDN Signs CRADA with U.S. Army to Study Commercialization of Rapid In-Field DNA Detection Technology

APDN Signs CRADA with U.S. Army to Study Commercialization of Rapid In-Field DNA Detection Technology

Woolam Cotton Gin Certified as First U.S. Organic Textile Processor Utilizing Applied DNA Organic Cotton Traceability System

Woolam Cotton Gin Certified as First U.S. Organic Textile Processor Utilizing Applied DNA Organic Cotton Traceability System

Applied DNA Reports Fiscal Third Quarter 2017 Financial Results

Applied DNA Reports Fiscal Third Quarter 2017 Financial Results

Applied DNA to Begin Production Testing with Major US-based Bearings Manufacturer

Applied DNA to Begin Production Testing with Major US-based Bearings Manufacturer

Applied DNA Completes Large-Scale Molecular Tagging of Fertilizer Successfully Tracked Through West African Supply Chain to Assure Security and Sustainability

Applied DNA Completes Large-Scale Molecular Tagging of Fertilizer Successfully Tracked Through West African Supply Chain to Assure Security and Sustainability

Applied DNA Schedules Fiscal 2017 Third Quarter Financial Results Conference Call and Webcast For August 10, 2017 at 4:30 PM ET

Applied DNA Schedules Fiscal 2017 Third Quarter Financial Results Conference Call and Webcast For August 10, 2017 at 4:30 PM ET

Events and Presentations

IR Calendar

December 6-7, 2017 | Imperial Capital 14th Annual Security Investor Conference | New York, NY

Presentation to followWebcast to follow

September 27, 2017 | 2017 Disruptive Growth Company Showcase | New York, NY

Presentation to followWebcast

August 10, 2017 | Applied DNA Sciences Fiscal Third Quarter 2017 Conference Call | Stony Brook, NY

Archived webcast of earnings conference call (audio and slide presentation): https://services.choruscall.com/links/apdn170810.html

June 6, 2017 | LD Microcap Conference | Los Angeles, NY

March 8, 2017 | Applied DNA Sciences Annual Meeting of Stockholders | Stony Brook, NY

Online Investor Kit

Corporate Governance

Board of Directors

Applied DNA’s Board of Directors consists of individuals with proven leadership skills, broad management experience in established companies, and their reputation as independent thinkers.

With experience in fields ranging from Bioagriculture to Zoology, the company will continue to benefit from the Board’s diversity of experience and opinions.

 

James A. Hayward, Phd., Sc.D

Chairman of the Board, President and Chief Executive Officer

Annual Meeting